Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1985;363(3):149-63.
doi: 10.1007/BF01261289.

[Therapeutic pancreatic duct occlusion in chronic pancreatitis: clinical, exocrine and endocrine consequences in a 12 month follow-up study]

[Article in German]
Clinical Trial

[Therapeutic pancreatic duct occlusion in chronic pancreatitis: clinical, exocrine and endocrine consequences in a 12 month follow-up study]

[Article in German]
M U Schneider et al. Langenbecks Arch Chir. 1985.

Abstract

Therapeutic pancreatic duct occlusion (PDO) is applied to preserve endocrine pancreatic function by atrophizing and thus eliminating chronically inflamed exocrine pancreatic parenchyma. So far, efficient and lasting elimination of exocrine parenchyma is brought about only by intraoperative PDO upon partial duodenopancreatectomy. While partial duodenopancreatectomy itself reduces endocrine pancreatic function by about 40%, intraoperative PDO does not further impair endocrine function. Endocrine function is not affected at all by endoscopic PDO, which has to be improved, however, concerning its eliminatory effect on exocrine pancreatic parenchyma.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Dtsch Med Wochenschr. 1977 Mar 18;102(11):392-5 - PubMed
    1. Dtsch Med Wochenschr. 1970 Jan 2;95(1):1-7 - PubMed
    1. Hepatogastroenterology. 1982 Jun;29(3):115-9 - PubMed
    1. Acta Med Scand. 1972 Nov;192(5):465-70 - PubMed
    1. Klin Wochenschr. 1961 Dec 1;39:1244-7 - PubMed

MeSH terms

LinkOut - more resources